BNP Paribas Financial Markets’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4K Sell
1,310
-27
-2% -$414 ﹤0.01% 5105
2025
Q4
$17K Sell
1,337
-4,865
-78% -$66.3K ﹤0.01% 5059
2025
Q3
$88.7K Sell
6,202
-10,808
-64% -$151K ﹤0.01% 4349
2025
Q2
$207K Buy
17,010
+10,600
+165% +$116K ﹤0.01% 3759
2025
Q1
$70.7K Buy
6,410
+100
+2% +$1.12K ﹤0.01% 4165
2024
Q4
$44.2K Buy
+6,310
New +$50.7K ﹤0.01% 4471

Other funds holding GHRS

BNP Paribas Financial Markets's GHRS Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its GH Research (GHRS) stake by 2% in Q1 2026, selling an estimated $414 and leaving 1,310 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5105.

BNP Paribas Financial Markets first reported a position in GHRS in Q4 2024 and has held it in 6 quarters since. The position peaked at $207K in Q2 2025. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • BNP Paribas Financial Markets held 1,310 shares of GH Research worth $18.4K as of Q1 2026.
  • BNP Paribas Financial Markets sold 27 GH Research shares in Q1 2026, an estimated $414.
  • GH Research made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5105 holding.
  • BNP Paribas Financial Markets first reported a position in GH Research in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's GH Research position peaked at $207K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.